Merck, Pfizer and Bristol-Myers Squibb Pharmaceutical Products Ahead of Earnings Results

Merck & Co. Inc. Zetia brand medication, used to treat high-cholesterol, is arranged for a photograph in a pharmacy in Princeton, Illinois, U.S., on Monday, April 27, 2015. Merck & Co. Inc. is expected to release quarterly earnings on April 28. Photographer: Daniel Acker/Bloomberg via Getty Images
Merck & Co. Inc. Zetia brand medication, used to treat high-cholesterol, is arranged for a photograph in a pharmacy in Princeton, Illinois, U.S., on Monday, April 27, 2015. Merck & Co. Inc. is expected to release quarterly earnings on April 28. Photographer: Daniel Acker/Bloomberg via Getty Images
Merck, Pfizer and Bristol-Myers Squibb Pharmaceutical Products Ahead of Earnings Results
PURCHASE A LICENCE
How can I use this image?
AED 1,850.00
AED

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
471365126
Collection:
Bloomberg
Date created:
27 April, 2015
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
MERCK EARNS
Max file size:
4000 x 2670 px (33.87 x 22.61 cm) - 300 dpi - 1 MB